Batten disease: Difference between revisions
From Food & Medicine Encyclopedia
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{Infobox medical condition | |||
| name = Batten disease | |||
| synonyms = Neuronal ceroid lipofuscinosis (NCL) | |||
| field = [[Neurology]], [[Genetics]] | |||
| symptoms = [[Seizures]], [[vision loss]], [[cognitive decline]], [[motor skills deterioration]] | |||
| onset = Childhood | |||
| duration = Progressive | |||
| causes = [[Genetic mutation]] | |||
| risks = [[Family history]] | |||
| diagnosis = [[Genetic testing]], [[clinical evaluation]] | |||
| treatment = [[Symptomatic treatment]], [[supportive care]] | |||
| prognosis = Poor | |||
| frequency = Rare | |||
}} | |||
{{Short description|A rare, fatal autosomal recessive neurodegenerative disorder}} | {{Short description|A rare, fatal autosomal recessive neurodegenerative disorder}} | ||
{{Use dmy dates|date=October 2023}} | {{Use dmy dates|date=October 2023}} | ||
'''Batten disease''', also known as '''neuronal ceroid lipofuscinosis''' (NCL), is a group of rare, fatal, inherited disorders of the nervous system that typically begin in childhood. It is the most common form of a group of disorders called the neuronal ceroid lipofuscinoses. | '''Batten disease''', also known as '''neuronal ceroid lipofuscinosis''' (NCL), is a group of rare, fatal, inherited disorders of the nervous system that typically begin in childhood. It is the most common form of a group of disorders called the neuronal ceroid lipofuscinoses. | ||
==Overview== | ==Overview== | ||
Batten disease is characterized by the accumulation of lipopigments in the body's tissues. These lipopigments are made up of fats and proteins. The name of the disease comes from the British pediatrician Frederick Batten, who first described the juvenile form of the disease in 1903. | Batten disease is characterized by the accumulation of lipopigments in the body's tissues. These lipopigments are made up of fats and proteins. The name of the disease comes from the British pediatrician Frederick Batten, who first described the juvenile form of the disease in 1903. | ||
==Symptoms== | ==Symptoms== | ||
The symptoms of Batten disease vary depending on the specific type and age of onset, but they generally include: | The symptoms of Batten disease vary depending on the specific type and age of onset, but they generally include: | ||
* Progressive vision loss leading to blindness | * Progressive vision loss leading to blindness | ||
* Seizures | * Seizures | ||
| Line 16: | Line 27: | ||
* Behavioral changes | * Behavioral changes | ||
* Loss of motor skills | * Loss of motor skills | ||
==Types== | ==Types== | ||
Batten disease is classified into several types based on the age of onset and the specific genetic mutation involved: | Batten disease is classified into several types based on the age of onset and the specific genetic mutation involved: | ||
* '''Infantile NCL (INCL)''': Symptoms appear between 6 months and 2 years of age. | * '''Infantile NCL (INCL)''': Symptoms appear between 6 months and 2 years of age. | ||
* '''Late Infantile NCL (LINCL)''': Symptoms appear between ages 2 and 4. | * '''Late Infantile NCL (LINCL)''': Symptoms appear between ages 2 and 4. | ||
* '''Juvenile NCL (JNCL)''': Symptoms appear between ages 5 and 8. | * '''Juvenile NCL (JNCL)''': Symptoms appear between ages 5 and 8. | ||
* '''Adult NCL (ANCL)''': Symptoms appear in adulthood. | * '''Adult NCL (ANCL)''': Symptoms appear in adulthood. | ||
==Genetics== | ==Genetics== | ||
Batten disease is inherited in an [[autosomal recessive]] pattern, meaning that both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition. | Batten disease is inherited in an [[autosomal recessive]] pattern, meaning that both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition. | ||
==Diagnosis== | ==Diagnosis== | ||
Diagnosis of Batten disease involves a combination of clinical evaluation, genetic testing, and laboratory tests. These may include: | Diagnosis of Batten disease involves a combination of clinical evaluation, genetic testing, and laboratory tests. These may include: | ||
* [[Electroencephalogram]] (EEG) | * [[Electroencephalogram]] (EEG) | ||
* [[Magnetic resonance imaging]] (MRI) | * [[Magnetic resonance imaging]] (MRI) | ||
* [[Genetic testing]] | * [[Genetic testing]] | ||
* [[Enzyme assay]] | * [[Enzyme assay]] | ||
==Treatment== | ==Treatment== | ||
Currently, there is no cure for Batten disease, and treatment is symptomatic and supportive. Management may include: | Currently, there is no cure for Batten disease, and treatment is symptomatic and supportive. Management may include: | ||
* [[Anticonvulsant]] medications to control seizures | * [[Anticonvulsant]] medications to control seizures | ||
* Physical therapy | * Physical therapy | ||
* Occupational therapy | * Occupational therapy | ||
* Educational support | * Educational support | ||
==Prognosis== | ==Prognosis== | ||
The prognosis for individuals with Batten disease is poor, as it is a progressive and fatal disorder. The rate of progression and life expectancy vary depending on the type of Batten disease. | The prognosis for individuals with Batten disease is poor, as it is a progressive and fatal disorder. The rate of progression and life expectancy vary depending on the type of Batten disease. | ||
==Research== | ==Research== | ||
Research is ongoing to find better treatments and ultimately a cure for Batten disease. This includes studies on gene therapy, enzyme replacement therapy, and other potential therapeutic approaches. | Research is ongoing to find better treatments and ultimately a cure for Batten disease. This includes studies on gene therapy, enzyme replacement therapy, and other potential therapeutic approaches. | ||
==Related pages== | ==Related pages== | ||
* [[Neurodegenerative disease]] | * [[Neurodegenerative disease]] | ||
* [[Genetic disorder]] | * [[Genetic disorder]] | ||
* [[Seizure disorder]] | * [[Seizure disorder]] | ||
[[Category:Neurodegenerative disorders]] | [[Category:Neurodegenerative disorders]] | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Rare diseases]] | [[Category:Rare diseases]] | ||
Latest revision as of 22:09, 3 April 2025
| Batten disease | |
|---|---|
| Synonyms | Neuronal ceroid lipofuscinosis (NCL) |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Seizures, vision loss, cognitive decline, motor skills deterioration |
| Complications | N/A |
| Onset | Childhood |
| Duration | Progressive |
| Types | N/A |
| Causes | Genetic mutation |
| Risks | Family history |
| Diagnosis | Genetic testing, clinical evaluation |
| Differential diagnosis | N/A |
| Prevention | N/A |
| Treatment | Symptomatic treatment, supportive care |
| Medication | N/A |
| Prognosis | Poor |
| Frequency | Rare |
| Deaths | N/A |
Batten disease, also known as neuronal ceroid lipofuscinosis (NCL), is a group of rare, fatal, inherited disorders of the nervous system that typically begin in childhood. It is the most common form of a group of disorders called the neuronal ceroid lipofuscinoses.
Overview[edit]
Batten disease is characterized by the accumulation of lipopigments in the body's tissues. These lipopigments are made up of fats and proteins. The name of the disease comes from the British pediatrician Frederick Batten, who first described the juvenile form of the disease in 1903.
Symptoms[edit]
The symptoms of Batten disease vary depending on the specific type and age of onset, but they generally include:
- Progressive vision loss leading to blindness
- Seizures
- Movement disorders
- Dementia
- Behavioral changes
- Loss of motor skills
Types[edit]
Batten disease is classified into several types based on the age of onset and the specific genetic mutation involved:
- Infantile NCL (INCL): Symptoms appear between 6 months and 2 years of age.
- Late Infantile NCL (LINCL): Symptoms appear between ages 2 and 4.
- Juvenile NCL (JNCL): Symptoms appear between ages 5 and 8.
- Adult NCL (ANCL): Symptoms appear in adulthood.
Genetics[edit]
Batten disease is inherited in an autosomal recessive pattern, meaning that both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.
Diagnosis[edit]
Diagnosis of Batten disease involves a combination of clinical evaluation, genetic testing, and laboratory tests. These may include:
Treatment[edit]
Currently, there is no cure for Batten disease, and treatment is symptomatic and supportive. Management may include:
- Anticonvulsant medications to control seizures
- Physical therapy
- Occupational therapy
- Educational support
Prognosis[edit]
The prognosis for individuals with Batten disease is poor, as it is a progressive and fatal disorder. The rate of progression and life expectancy vary depending on the type of Batten disease.
Research[edit]
Research is ongoing to find better treatments and ultimately a cure for Batten disease. This includes studies on gene therapy, enzyme replacement therapy, and other potential therapeutic approaches.
